CRISPR Meets Synthetic Biology: A Conversation with MIT’s Christopher Voigt
Type
Blog Post
...As Christopher Voigt explains it, his lab at the Massachusetts Institute of Technology has been “working...create an almost limitless number of DNA binding proteins with Cas9 guided by different promoters. The challenge... genetic circuits is getting enough regulatory proteins that don’t interfere with each other. CRISPR is...much easier it is to work with than regulatory proteins. There are still things we haven’t solved that...Nothing too much more sophisticated. There are also proteins, like antibodies. But we are really just using...